Category: Disease Prevention & Management

The Endocrine Society has officially announced that Samuel Klein, MD, the William H. Danforth Professor of Medicine and Nutritional Science at Washington University School of Medicine in St. Louis, is the 2026 recipient of the Outstanding Clinical Investigator Laureate Award. This prestigious recognition marks the culmination of over three decades of rigorous inquiry into the…

The medical community is currently witnessing a transformative era in the treatment of metabolic disorders, driven largely by the meteoric rise of glucagon-like peptide-1 receptor agonists (GLP-1RAs). These agents, once primarily utilized for the management of type 2 diabetes, have transcended their original clinical indications to become a cornerstone of obesity management and a subject…

Maria Andrea Camilletti, PhD, an assistant researcher at the Laboratorio de Investigaciones Aplicadas en Neurociencias (LIAN) within the Institute of Neuroscience (INEU-CONICET) at the Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) in Buenos Aires, is currently spearheading critical research into the genetic underpinnings of pituitary disorders. Representing the Endocrine Society’s…

The Endocrine Society, the world’s oldest and largest organization dedicated to hormone research and the clinical practice of endocrinology, has officially announced that its members have elected Joy Wu, MD, PhD, as the Society’s President for the 2027–2028 term. Dr. Wu, a distinguished physician-scientist currently serving at the Stanford University School of Medicine, will assume…

The Endocrine Society has officially announced that Dr. Rebecca Reynolds, MD, PhD, a distinguished leader in metabolic medicine, has been named the recipient of the 2026 International Excellence in Endocrinology Laureate Award. This prestigious recognition highlights Dr. Reynolds’ transformative contributions to the understanding of how endocrine pathways during pregnancy influence the long-term health of both…

Chicago is slated to become the epicenter of global endocrinology from June 13 to June 16, 2026, as the Endocrine Society brings its flagship annual meeting, ENDO 2026, to the McCormick Place West convention center. This prestigious gathering is expected to draw more than 7,200 clinicians, researchers, and medical professionals from across the globe, transforming…

The global landscape for metabolic medicine shifted significantly in October 2025 as pharmaceutical leader Eli Lilly and Company announced that its experimental once-daily oral medication, orforglipron, successfully met all primary and secondary endpoints in two pivotal Phase 3 clinical trials. The trials, known as ACHIEVE-2 and ACHIEVE-5, provide the most robust evidence to date that…

The study provides a rigorous look at how semaglutide interacts with the immune system to inhibit the progression of PTC, the most common form of thyroid cancer. By investigating the GLP-1R/PPARG/ACSL1 signaling pathway, researchers have identified a process by which the drug "reprograms" immune cells, shifting them from a state that supports tumor growth to…

New research published in the Journal of the Endocrine Society suggests that a father’s exposure to nicotine may fundamentally alter the metabolic health of his offspring, potentially predisposing future generations to diabetes and other metabolic disorders. The study, led by researchers at the University of California, Santa Cruz (UCSC), utilizes a murine model to demonstrate…

In a strategic move to bolster its leadership in metabolic research and clinical care, NYU Langone Health has announced the appointment of Marcus D. Goncalves, MD, PhD, as the new director of the Holman Division of Endocrinology, Diabetes, and Metabolism. Dr. Goncalves, a distinguished physician-scientist with a focus on the intersection of systemic metabolism and…